Trial · NCT07909590
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Pain Intensity Before Using Panadol/Dolex | Within the past 1 month from time of participation | Thinking about most recent headache episode, participants will be asked to rate the pain intensity experienced before using Panadol/Dolex on a scale 0 to 10, where 0= No pain and 10= Worst possible pain. Lower score indicates better outcome. |
| Primary | Perceived Relief From Panadol/Dolex Use | Within the past 1 month from time of participation | Thinking about the headache episode, participants will describe the first sign of symptom relief they perceived after taking Panadol/Dolex. |
| Primary | QoL Assessment After Using Panadol/Dolex Post Headache Episode | Within the past 1 month from time of participation | Thinking about most recent headache episode, participants will be asked to respond to 10 questions related to aspects of daily life when they used Panadol/Dolex after headache episode. The response will be scored using a 5-point scale, where 1= Not at all, and 5= Very Much. Lower score indicates better quality of life. |
| Secondary | Frequency of Panadol/Dolex Use | Within the past 1 month from time of participation | Thinking about the recent headache episode, participants will be asked to mention the frequency of product use from 1 time a day to 4 times a day. |
| Secondary | Timepoint of Panadol/Dolex Use | Within the past 1 month from time of participation | Participants will answer a single question related to timepoint of product use- 'Thinking about the same headache episode which you used Panadol for relief in the past one month, what did you first do to relieve the pain?' Participants will choose one of the given options. |
| Secondary | Product Satisfaction | Within the past 1 month from time of participation | Thinking about the experience of using Panadol, participants will rate their overall satisfaction on a scale 1 to 5, where 1= Absolutely dissatisfied and 5= Completely satisfied. |
| Secondary | Headache Management Behaviors | Within the past 1 month from time of participation | Participants will answer a single question related to headache management approaches they used before- 'Thinking about similar headaches you experienced before this episode, what did you do to relieve your headache in the past?' Participants will select one or more descriptive options provided. |
| Secondary | User Attitudes Towards Panadol/Dolex: Trust in The Product | Within the past 1 month from time of participation | Participants will answer a single question related to trust in the product- 'How much do you trust the product to provide fast headache pain relief?' Participants will choose one of the given options. |
| Secondary | User Attitudes Towards Panadol/Dolex: Value For Money | Within the past 1 month from time of participation | Thinking about experience of using the product, participants will be asked to rate the product's value for money on a scale 1 to 5, where 1= Poor value for money and 5= Excellent value for money. |
| Secondary | User Attitudes Towards Panadol/Dolex: Intention to Use Again | Within the past 1 month from time of participation | Participants will answer a single question related to continued purchase- 'How likely would you choose Panadol again for your next headache episode?'. Participants will choose one of the given options. |
| Secondary | User Attitudes Towards Panadol/Dolex: Intention to Recommend Other Consumers | Within the past 1 month from time of participation | Participants will answer a single question related to likelihood to recommend others- How likely would you recommend Panadol to other consumers experiencing headache pain? Participants will choose one of the given options. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07909590/registered